Pfenex (PFNX) News Today $12.75 0.00 (0.00%) As of 10/1/2020 Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period NKY Medical Holdings Ltd Class A 300109January 31, 2024 | morningstar.comLigand Pharmaceuticals: Struggling Along (NASDAQ:LGND) - Seeking AlphaSeptember 25, 2022 | seekingalpha.comForte Biosciences, Inc. Announces Second Quarter 2022 Results and Provides Business Update - Business WireAugust 15, 2022 | businesswire.comLigand Reports Second Quarter 2022 Financial Results - Business WireAugust 9, 2022 | businesswire.com2022-08-08 | NDAQ:LGND | Press Release | Ligand Pharmaceuticals Incorporated - StockhouseAugust 8, 2022 | stockhouse.comOsteoporosis Therapeutics Market to Top US$ 14 Bn Valuation by 2026: Fact.MR Analysis - Yahoo FinanceMay 17, 2022 | finance.yahoo.comLigand Reports First Quarter 2022 Financial Results - StreetInsider.comMay 5, 2022 | streetinsider.comLigand Reports First Quarter 2022 Financial Results - Marketscreener.comMay 4, 2022 | marketscreener.comLigand Pharmaceuticals: Moving Parts Keep Moving - Seeking AlphaMarch 29, 2022 | seekingalpha.comGlobal Pharma, Biotech and Diagnostics Joint Venture Partnering Deal Terms and Agreements Analysis Report 2021 with Example Case Studies of Agila Specialties/Pfenex and Dance Biopharm/Harmony Asset - PR NewswireMarch 24, 2022 | prnewswire.comLigand Reports Fourth Quarter and Full Year 2021 Financial Results - Business WireFebruary 17, 2022 | businesswire.comPipeline Therapeutics Appoints Eef Schimmelpennink to its Board of Directors - Business WireFebruary 15, 2022 | businesswire.comLIGAND PHARMACEUTICALS INC : Termination of a Material Definitive Agreement (form 8-K) - marketscreener.comJanuary 14, 2022 | marketscreener.comDr. Hubert Chen Joins ADARx Pharmaceuticals as Chief Medical Officer - Business WireJanuary 5, 2022 | businesswire.comSolid Nutrition Unit to Aid Archer Daniels (ADM) Amid Cost Woes - NasdaqNovember 10, 2021 | nasdaq.comDare Bioscience, Inc. (DARE) Reports Q3 Loss, Lags Revenue Estimates - NasdaqNovember 10, 2021 | nasdaq.comfuboTV Falls 7% Despite Solid Q3 Results - NasdaqNovember 10, 2021 | nasdaq.comLIGAND PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - marketscreener.comNovember 9, 2021 | marketscreener.comLigand Reports Third Quarter 2021 Financial Results - Business WireNovember 9, 2021 | businesswire.comGlobal Joint Venture Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021 - B - BenzingaSeptember 23, 2021 | benzinga.comOphthalmology Biosimilars Market Report 2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Forecast - Yahoo FinanceSeptember 7, 2021 | yahoo.comLigand Pharmaceuticals Incorporated (LGND) Q2 2021 Earnings Call Transcript - Motley FoolJuly 30, 2021 | fool.comLigand Reports Second Quarter 2021 Financial Results - Business WireJuly 29, 2021 | businesswire.com Remove Ads Get Pfenex News Delivered to You Automatically Sign up to receive the latest news and ratings for PFNX and its competitors with MarketBeat's FREE daily newsletter. Email Address PFNX Media Mentions By Week PFNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PFNX News Sentiment▼0.000.78▲Average Medical News Sentiment PFNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PFNX Articles This Week▼00▲PFNX Articles Average Week Remove Ads Get Pfenex News Delivered to You Automatically Sign up to receive the latest news and ratings for PFNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BHC News TARS News BHVN News BLTE News NAMS News RXRX News DNLI News AAPG News HRMY News GLPG News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSEAMERICAN:PFNX) was last updated on 4/15/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pfenex Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pfenex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
